Literature DB >> 8285741

Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group.

J P Drenth1, B W Boom, J Toonstra, J W Van der Meer.   

Abstract

BACKGROUND AND
DESIGN: The hyperimmunoglobulinemia D (hyper-IgD) syndrome is characterized by recurrent febrile attacks with abdominal distress, headache, and arthralgias. Physical examination reveals cervical lymphadenopathy in most cases and, sometimes, splenomegaly. Skin lesions have been observed in isolated cases during attacks. We summarize the features of skin lesions and the histopathologic findings in biopsy specimens in the hyper-IgD syndrome.
RESULTS: A total of 44 patients with the hyper-IgD syndrome were studied. Thirty-five (79%) of them, 19 males and 16 females, had skin lesions during febrile attacks. Erythematous macules were the most common cutaneous manifestation (15 cases), followed by erythematous papules (12 cases); urticarial lesions (nine cases) and erythematous nodules (seven cases). Skin biopsy specimens of 10 patients with the hyper-IgD syndrome were available for review. The findings varied considerably. Most biopsy specimens showed mild features of vasculitis. Nonspecific findings were noted in five biopsy specimens; Sweet-like features in two, cellulitis-like findings in one, and deep vasculitis characteristics in one.
CONCLUSIONS: Skin lesions are common in the hyper-IgD syndrome suggesting that they are a true manifestation of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8285741

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  21 in total

Review 1.  Immunoglobulin D: properties, measurement, and clinical relevance.

Authors:  A O Vladutiu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 2.  New insights into the enigma of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  Hyperimmunoglobulinemia D in idiopathic retinal vasculitis.

Authors:  Y Kumano; T Nagato; K Kurihara; H Kikukawa; M Goto; Y Kawano; Y Ohnishi; H Inomata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 4.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

5.  Tendonitis in variant hyperimmunoglobulinaemia D and periodic fever syndrome--a rare disease with a new symptom.

Authors:  Sven Armbrust; Joost P H Drenth; Carmen Schröder; Ester Domning; Ernestine Poeschl; Siegfried K W Wiersbitzky
Journal:  Eur J Pediatr       Date:  2005-03-16       Impact factor: 3.183

Review 6.  Autoinflammatory Disease-Associated Vasculitis/Vasculopathy.

Authors:  Mansour Alghamdi
Journal:  Curr Rheumatol Rep       Date:  2018-11-17       Impact factor: 4.592

Review 7.  To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies.

Authors:  Annalisa Marcuzzi; Elisa Piscianz; Erica Valencic; Lorenzo Monasta; Liza Vecchi Brumatti; Alberto Tommasini
Journal:  Int J Mol Sci       Date:  2015-09-07       Impact factor: 5.923

8.  Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome.

Authors:  I S Klasen; J H Göertz; G A van de Wiel; C M Weemaes; J W van der Meer; J P Drenth
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

Review 9.  Clinical guidelines and definitions of autoinflammatory diseases: contrasts and comparisons with autoimmunity-a comprehensive review.

Authors:  M Zen; M Gatto; M Domeneghetti; L Palma; E Borella; L Iaccarino; L Punzi; A Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 10.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.